SomaLogic Partners with OncoHost for Precision Cancer Diagnostics
Proteomics technology company SomaLogic signed a licensing agreement with OncoHost to develop new cancer diagnostics solutions.
Read MorePosted by Andy Lundin | Jun 27, 2022 | Cancer, Diagnostic Technologies |
Proteomics technology company SomaLogic signed a licensing agreement with OncoHost to develop new cancer diagnostics solutions.
Read MorePosted by Andy Lundin | Jun 23, 2022 | Unknown Origin & Other Cancer Types |
Researchers developed a blood test to predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Company News, Diagnostic Technologies |
LightDeck Diagnostics has been awarded a grant to build a rapid, portable, quantitative test to detect many PFAS simultaneously.
Read MorePosted by Andy Lundin | Jun 21, 2022 | Covid 19, Fluid Handling & Pipetting Systems |
Matrix Diagnostics—a COVID testing lab based in California—is relying on INTEGRA Biosciences’ pipettes to streamline its PCR workflows.
Read More